The effect of 24,25 dihydroxyvitamin D3 on calcium efflux: the role of protein kinase C
- 28 June 1998
- journal article
- research article
- Published by Wiley in Nephrology
- Vol. 4 (3) , 157-162
- https://doi.org/10.1046/j.1440-1797.1998.d01-26.x
Abstract
SUMMARY: 24,25 dihydroxyvitamin D3 (24,25(OH)2D3) is more abundant than 1,25(OH)2D3 in the serum. 1,25 dihydroxyvitamin D3, a potent calciotropic metabolite of vitamin D, has been shown to induce calcium efflux from bone. This action is probably mediated, in part, by protein kinase C (PKC). to determine whether 24,25(OH)2D3 affects calcium flux in bone, neonatal rat calvaria were cultured and the effect of 24,25(OH)2D3 on calcium flux and signal transduction pathways were evaluated. Compared with a control, 24,25(OH)2D3 (108 mol/L) inhibited basal net calcium efflux. 24,25 dihydroxyvitamin D3 also inhibited net calcium efflux induced by the phorbol ester 12 Myristate 13‐Acetate (PMA). Translocation of PKC from the membrane to the cytosolic fraction was rapidly and transiently induced by 24,25(OH)2D3. However, 24,25(OH)2D3 had no effect on cyclic AMP (cAMP) production. In conclusion, 24,25(OH)2D3 has a direct effect on bone by inhibiting net calcium efflux which is probably mediated by the deactivation of PKC.Keywords
This publication has 20 references indexed in Scilit:
- 24R, 25‐Dihydroxyvitamin D3 ameliorates the high‐turnover bone diseases without suppressing parathyroid function in chronic renal failure in ratsNephrology, 1996
- 22-Oxacalcitriol does not interfere with parathyroid hormone-induced phosphaturia or cyclic-AMP excretionBone, 1995
- Effects of 24r,25-dihydroxyvitamin D3 in combination with 1α-hydroxyvitamin D3 in predialysis renal insufficiency: Biochemistry and histomorphometry of cancellous boneJournal of Bone and Mineral Research, 1995
- Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cellsCalcified Tissue International, 1993
- Assessment of combined 24,25(oh)2d3 and 1α(oh)d3 therapy for bone disease in dialysis patientsBone, 1992
- Increased bone volume and reduced bone turnover in vitamin D-replete rabbits by the administration of 24R,25-dihydroxyvitamin D3Bone, 1992
- 24,25(OH)2D3 affects the calcemic effects of 1,25(OH)2D3 by mechanisms independent of intestinal calcium absorptionBone and Mineral, 1991
- Suppressive Effects of 24,25-Dihydroxycholecalciferol on Bone Resorption Induced by Acute Bilateral Nephrectomy in RatsJournal of Clinical Investigation, 1981
- Studies on the mode of action of calciferol XXXII. Evidence for a 24(R),25(OH)2-vitamin D3 receptor in the parathyroid gland of the rachitic chickBiochemical and Biophysical Research Communications, 1981
- Specific nuclear uptake of 24,25‐dihydroxycholecalciferol, a vitamin D3 metabolite biologically active in cartilageFEBS Letters, 1980